GREGOIRE LE GAL profile picture

Contact Information

GREGOIRE LE GAL, MD, PhD
613-737-8899, ext 73034
glegal@ohri.ca

ORCID logo https://orcid.org/0000-0002-9253-248X

News

Honouring our top researchers of 2024
November 7, 2024 - Each year, The Ottawa Hospital and its Research Institute honour a small number of outstanding researchers for discoveries and innovations that are improving patient care at TOH and advancing science around the world.
Researchers at The Ottawa Hospital awarded 13 CIHR grants worth more than $7 million
July 21, 2023 - Researchers at The Ottawa Hospital are playing a lead role in 13 new projects awarded more than $7 million from the Canadian Institutes of Health Research (CIHR).
Tiny clots in the lung put patients at risk of future blood clots
December 16, 2021 - A study led by Drs. Grégoire Le Gal and Marc Carrier found that tiny clots in the lungs are not as harmless as previously thought, and in most cases should be treated with blood thinners.
Study establishes bleeding risk with long-term use of blood thinners for life-threatening clots
October 20, 2021 - A new systematic review and meta-analysis now provides the best data yet on the long-term risks and consequences of bleeding with different blood thinners.
The Ottawa Hospital awarded six CIHR grants worth $2.6 million
September 7, 2020 - Could a common diabetes drug help prevent ovarian cancer? Can a tailored screening program help prevent eye disease in immigrants? Is sepsis different in females versus males, and if so, can this help us develop better treatments? These are just ...
Researchers awarded $1.6M to improve care for cardiovascular disease
November 13, 2019 - The Heart and Stroke Foundation of Canada has awarded $1.6M to researchers at The Ottawa Hospital, affiliated with the University of Ottawa.
The Ottawa Hospital awarded 13 grants worth $11.2 million from Canadian Institutes of Health Research
July 26, 2019 - Researchers at The Ottawa Hospital have been awarded 13 grants worth a total of $11.2 million from the Canadian Institutes of Health Research (CIHR). The new projects focus on areas such as cancer immunotherapy, hepatitis C infection, blood ...
Drug dramatically reduces risk of dangerous blood clots in cancer patients
December 4, 2018 - A Canadian clinical trial published in the New England Journal of Medicine provides the first approach for safely preventing blood clots (or venous thromboembolism) in people with cancer. About half of people newly diagnosed with a solid cancer ...
Tattoo artist grateful to be off blood thinners thanks to made-in-Ottawa rule
April 26, 2017 - Ottawa resident Sarah Rogers would have been taking blood thinners for life, if not for a rule that showed she was at low risk of having a second blood clot. Ottawa tattoo artist Sarah Rogers thought she’d pulled a muscle when her right leg star
Over 10,000 Canadian women per year can stop taking blood thinners for unexplained vein clots
April 4, 2017 - Rule identifies women who have low risk of vein blood clot recurrence A Canadian-led research group has developed and validated a rule that could let half of women with unexplained vein blood clots stop taking blood thinners for life. These find